Skip to content

Observational Prospective Clinical Investigation on Monofocal Toric Intraocular Lens

At Least One-year Long-term Clinical Outcomes Following Monofocal Toric Intraocular Lens Implantation: Observational Prospective Clinical Investigation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06250855
Enrollment
105
Registered
2024-02-09
Start date
2024-04-24
Completion date
2024-10-27
Last updated
2025-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Cataract

Keywords

Cataract, Astigmatism, Monofocal IOL, Toric IOL

Brief summary

Evaluation, at least one-year long-term, of the clinical performance and safety of Mini Toric Ready Intraocular Lens (IOL), a monofocal toric intraocular lens.

Detailed description

Observational prospective clinical investigation based on the medical records of patients who undergone uncomplicated cataract surgery with implantation of Mini Toric Ready IOL and on a clinical visit after at least one year from the surgery. Eyes with corneal astigmatism ≥0.75 diopters were included. Postoperative evaluations included monocular or binocular uncorrected and corrected distance visual acuity; contrast sensitivity measured after at least one-year postoperatively.

Interventions

DEVICEMini Toric IOL

Adults (males and females) ≥18 years with cataract and pre-existing corneal astigmatism who have undergone monocular or binocular Mini Toric Ready implantation after cataract surgery in which the cataract lens was removed by phacoemulsification, with circular capsulorhexis, leaving the posterior capsule intact.

Sponsors

SIFI SpA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Eighteen years of age or older at the time of surgery and diagnosed with unilateral or bilateral cataracts; * Preoperative total corneal astigmatism ≥0.75D; * Unilateral or bilateral cataract removal by phacoemulsification; * Clear intraocular media other than cataract; * Willing and able to complete all required postoperative visits; * Able to comprehend and sign a statement of informed consent consistent with local regulation for research in human subjects.

Exclusion criteria

* Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days before the surgery.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the Visual PerformanceFrom 12 to 24 months post-surgeryEvaluate Mini Toric Ready Intraocular Lens (IOL) performance in terms of correction of spherical and cylindrical visual defects, corrected and uncorrected monocular and/or binocular distance visual acuity at least 12 months post implant.

Secondary

MeasureTime frameDescription
Evaluation of the StabilityFrom 12 to 24 months post-surgeryIntraocular Lens (IOL) Rotation Stability

Other

MeasureTime frameDescription
Evaluation of the safety profile: Adverse Events (AEs)From 12 to 24 months post-surgeryIncidence of Adverse events such as Posterior Capsular Opacification (PCO)
Evaluation of the safety profileFrom 12 to 24 months post-surgeryRate of secondary surgical interventions (SSIs) related to the optical properties of the IOL after at least 12 months post implant.

Countries

Romania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026